Abstract
Heart transplantation remains the gold standard treatment for patients with end-stage heart failure. In the USA, the number of available donors has remained stable despite the steadily increasing need for organs. Optimal donor selection and management are critical to deriving the greatest benefit from this limited resource. Methods to expand the donor pool without compromising long-term outcomes for heart recipients are needed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have